2023
Barriers to Care Among Sexual and Gender Minority Individuals With Chronic Inflammatory Skin Diseases in the US
Nock M, Kamal K, Zampella J, Roberson M, Cohen J, Barbieri J. Barriers to Care Among Sexual and Gender Minority Individuals With Chronic Inflammatory Skin Diseases in the US. JAMA Dermatology 2023, 159: 1323-1331. PMID: 37755822, PMCID: PMC10535014, DOI: 10.1001/jamadermatol.2023.3328.Peer-Reviewed Original ResearchConceptsChronic inflammatory skin diseaseInflammatory skin diseaseHealth care practitionersCross-sectional studySGM patientsPrevalence of barriersCare practitionersGender minority patientsSkin diseasesMinority patientsMAIN OUTCOMEHealth careMultivariable logistic regressionHealth care accessMental health careSpecialist careCare accessPatientsUs Research ProgramLogistic regressionCarePrevalenceDiseaseNational InstituteGender minority individualsAssessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology
Mortlock R, Ma E, Cohen J, Damsky W. Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology. Journal Of Investigative Dermatology 2023, 143: 1412-1422. PMID: 37341663, PMCID: PMC10830170, DOI: 10.1016/j.jid.2023.04.005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAtopic dermatitisSkin diseasesInflammatory skin diseaseInflammatory skin conditionImmunologic biomarkersImmune biomarkersPersonalized medicineInflammatory dermatosesImmunologic approachesTherapy selectionSkin conditionsSingle-cell RNA sequencingMolecular profilingBiomarkersTissue stainingPsoriasisDermatitisDiseaseDermatologyRNA sequencingMedicineCurettageDermatosesTherapyPersonalized classification
2022
Racial and ethnic differences in barriers to care among US adults with chronic inflammatory skin diseases: A cross-sectional study of the All of Us Research Program
Nock MR, Barbieri JS, Krueger LD, Cohen JM. Racial and ethnic differences in barriers to care among US adults with chronic inflammatory skin diseases: A cross-sectional study of the All of Us Research Program. Journal Of The American Academy Of Dermatology 2022, 88: 568-576. PMID: 36244557, DOI: 10.1016/j.jaad.2022.09.054.Peer-Reviewed Original ResearchConceptsChronic inflammatory skin diseaseInflammatory skin diseaseCross-sectional studyHispanic patientsUS adultsSkin diseasesUs Research ProgramEthnic differencesEthnic minority patientsHealth care workforce diversityWhite patientsAdult careMinority patientsMultivariable regressionPatientsDermatologic careCareDiseaseRepresentative sampleAdultsEthnic groupsStructural barriersEthnicityRural areasPrevalence
2020
A novel medical student initiative to enhance provision of teledermatology in a resident continuity clinic during the COVID‐19 pandemic: a pilot study
Belzer A, Olamiju B, Antaya RJ, Odell ID, Bia M, Perkins SH, Cohen JM. A novel medical student initiative to enhance provision of teledermatology in a resident continuity clinic during the COVID‐19 pandemic: a pilot study. International Journal Of Dermatology 2020, 60: 128-129. PMID: 33226121, PMCID: PMC7753449, DOI: 10.1111/ijd.15322.Peer-Reviewed Original ResearchPatient and physician perspectives on teledermatology at an academic dermatology department amid the COVID-19 pandemic
Asabor EN, Bunick CG, Cohen JM, Perkins SH. Patient and physician perspectives on teledermatology at an academic dermatology department amid the COVID-19 pandemic. Journal Of The American Academy Of Dermatology 2020, 84: 158-161. PMID: 32946971, PMCID: PMC7491373, DOI: 10.1016/j.jaad.2020.09.029.Peer-Reviewed Original ResearchThe new normal: An approach to optimizing and combining in-person and telemedicine visits to maximize patient care
Cohen JM, Bunick CG, Perkins SH. The new normal: An approach to optimizing and combining in-person and telemedicine visits to maximize patient care. Journal Of The American Academy Of Dermatology 2020, 83: e361-e362. PMID: 32593636, PMCID: PMC7316470, DOI: 10.1016/j.jaad.2020.06.075.Peer-Reviewed Original Research
2019
Top dermatologic diagnoses by gender in the United States
Steuer AB, Cohen JM, Zampella JG. Top dermatologic diagnoses by gender in the United States. International Journal Of Dermatology 2019, 59: e206-e208. PMID: 31769011, DOI: 10.1111/ijd.14736.Peer-Reviewed Original Research
2015
Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects
Xue Y, Cohen JM, Wright NA, Merola JF. Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects. American Journal Of Clinical Dermatology 2015, 17: 147-162. PMID: 26649439, DOI: 10.1007/s40257-015-0167-z.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousAntirheumatic AgentsArthritis, RheumatoidBiological TherapyDermatomyositisDrug EruptionsHumansLichenoid EruptionsLupus Erythematosus, CutaneousMelanomaPyoderma GangrenosumRheumatoid NoduleRheumatoid VasculitisSkin DiseasesSkin NeoplasmsSweet SyndromeTumor Necrosis Factor-alphaConceptsRheumatoid arthritisAdverse effectsBiologic disease-modifying agentsManagement of RAAnti-TNFα agentsRA disease activityCutaneous adverse effectsSystemic inflammatory disorderCutaneous side effectsDisease-modifying agentsGranulomatous skin disorderConnective tissue disordersNeutrophilic dermatosisRheumatoid vasculitisDisease activityAggressive treatmentRheumatoid nodulesCutaneous findingsClinical presentationTherapeutic challengeGranulomatous conditionsInflammatory disordersSkin signsCutaneous diseaseCutaneous effects